JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5151
Asure Software
ASUR
$222M
| $264K | ﹤0.01% |
28,010
+17,329
| +162% | +$159K |
2020 Q2
18 quarters
|
|
5152
Mama's Creations
MAMA
$610M
| $263K | ﹤0.01% |
32,999
-25,843
| -44% | -$214K |
2023 Q3
5 quarters
|
|
5153
Lightspeed Commerce
LSPD
$1.27B
| $261K | ﹤0.01% |
17,137
| – | – |
2020 Q3
17 quarters
|
|
|
MRNS
5154
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $261K | ﹤0.01% |
487,584
+354,393
| +266% | +$247K |
2018 Q1
27 quarters
|
|
5155
Aehr Test Systems
AEHR
$3.5B
| $259K | ﹤0.01% |
15,591
+2,076
| +15% | +$27.7K |
2022 Q4
8 quarters
|
|
5156
Paysafe
PSFE
$281M
| $257K | ﹤0.01% |
15,056
-127
| -0.8% | -$2.57K |
2021 Q1
15 quarters
|
|
5157
inTEST
INTT
$158M
| $257K | ﹤0.01% |
29,915
-7,566
| -20% | -$57.3K |
2023 Q2
6 quarters
|
|
5158
Adams Diversified Equity Fund
ADX
$3.22B
| $257K | ﹤0.01% |
12,701
+702
| +6% | +$15K |
2015 Q4
36 quarters
|
|
5159
Humacyte
HUMA
$145M
| $256K | ﹤0.01% |
50,644
-1,191
| -2% | -$5.89K |
2021 Q4
12 quarters
|
|
|
IMA
5160
ImageneBio Inc
IMA
$52.2M
| $255K | ﹤0.01% |
12,978
+12,907
| +18,179% | +$261K |
2021 Q2
14 quarters
|
|
5161
State Street Global Allocation ETF
GAL
$315M
| $253K | ﹤0.01% |
5,725
+3,478
| +155% | +$157K |
2024 Q2
2 quarters
|
|
5162
Evolution Petroleum
EPM
$144M
| $253K | ﹤0.01% |
48,336
+34,125
| +240% | +$187K |
2017 Q3
29 quarters
|
|
5163
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$113M
| $252K | ﹤0.01% |
10,132
+10,090
| +24,024% | +$261K |
2023 Q4
4 quarters
|
|
5164
Universal Electronics
UEIC
$73.1M
| $252K | ﹤0.01% |
22,865
+5,042
| +28% | +$50.4K |
2013 Q2
46 quarters
|
|
5165
PUT
KKR & Co
KKR
$81B
| $251K | ﹤0.01% |
1,700
+1,100
| +183% | +$161K |
2024 Q2
2 quarters
|
|
5166
WisdomTree Mortgage Plus Bond Fund
MTGP
$71.3M
| $250K | ﹤0.01% |
5,797
-443
| -7% | -$19.5K |
2023 Q2
6 quarters
|
|
5167
ProShares UltraPro Dow 30
UDOW
$848M
| $250K | ﹤0.01% |
5,292
+1,562
| +42% | +$79K |
2024 Q3
1 quarter
|
|
5168
Brown-Forman Class A
BF.A
$12.2B
| $249K | ﹤0.01% |
6,600
-2,507
| -28% | -$108K |
2015 Q4
36 quarters
|
|
|
ASAI
5169
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $249K | ﹤0.01% |
55,625
+55,536
| +62,400% | +$324K |
2024 Q2
2 quarters
|
|
5170
Invesco New York AMT-Free Municipal Bond ETF
PZT
$129M
| $248K | ﹤0.01% |
10,943
+10,230
| +1,435% | +$236K |
2024 Q2
2 quarters
|
|
5171
Centuri Holdings
CTRI
$2.11B
| $248K | ﹤0.01% |
12,850
+1,335
| +12% | +$25.9K |
2024 Q2
2 quarters
|
|
5172
Corsair Gaming
CRSR
$1.49B
| $248K | ﹤0.01% |
37,527
-1,902
| -5% | -$13.2K |
2020 Q3
17 quarters
|
|
5173
Standard BioTools
LAB
$292M
| $246K | ﹤0.01% |
140,459
+711
| +0.5% | +$1.32K |
2016 Q4
32 quarters
|
|
5174
Strawberry Fields REIT
STRW
$191M
| $246K | ﹤0.01% |
23,305
+13,733
| +143% | +$159K |
2023 Q4
4 quarters
|
|
5175
Blue Ridge Bankshares
BRBS
$352M
| $245K | ﹤0.01% |
76,151
+75,709
| +17,129% | +$238K |
2021 Q2
14 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.